Compositions and methods relating to salts of specialized pro-resolving mediators
AssigneeThetis Pharmaceuticals LLC
InventorsFrank C. Sciavolino, Gary Mathias, Michael C. Van Zandt, Gunnar Erik Jagdmann, Jr., Jessica J. Dworak
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of Formula IV, compositions comprising same, and their use in therapy wherein A and B are each independently a specialized pro-resolving mediator (“SPM”) molecule selected from an E series resolvin, a D series resolvin, and their aspirin-triggered counterparts, and M, R1, R2, X1and X2 are as defined herein.
Claims22
A compound of Formula IV which contains a scaffold of two amino acid moieties coordinated around a divalent metal and one or two SPM molecules A, B, ionically bound to at least one basic function provided by the scaffold:
- wherein
- M is a divalent metal selected from magnesium (Mg2+) and calcium (Ca2+),
- A and B are each independently an SPM molecule selected from an E series resolvin, a D series resolvin, and their aspirin-triggered counterparts,
- A and B may be the same or different,
- either A or B, but not both, may be absent,
- R1 and R2 are each independently —(CH2)3—Y1, and —(CH2)4—Y2,
- where Y1 and Y2 are each a basic function selected from a positively charged primary amine, a positively charged secondary amine, a positively charged tertiary amine, and a positively charged guanidine,
- X1 and X2 are each independently H or CO—Z and Z is a peptide comprising 1 to 5 amino acids.
Dependencies are inferred from the claim text.